相关实验视频
Updated: May 11, 2026
09:27
The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
Published on: June 17, 2016
12.2K
亚斯科布酸可以改善异化物 - - 里法素诱导的肝细胞损伤在老鼠
Shubham Patel1, Aman Chaturvedi1, Nazneen Dubey1
1Shri Ram Institute of Technology-Pharmacy, Jabalpur, India.
ILIVER..
|July 10, 2025
概括
亚斯科布酸在老鼠中表现出显著的肝保护作用,防止因异化和利芬素引起的肝损伤. 它的激素清除和细胞因子抑制特性是这种保护作用的关键.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 生物化学 生物化学
背景情况:
- 植物成分因其肝脏保护性质而闻名.
- 亚酸的强大激素清除能力已经得到了充分的证据.
- 已知异化和利芬素会诱导肝损伤.
研究的目的:
- 为了研究阿斯科布酸的肝脏保护功效.
- 评估阿斯科布酸对异亚胺和利芬素诱导的肝损伤的作用. 在大鼠模型中.
主要方法:
- 威斯塔大鼠被给予异化和利芬素,以诱导肝毒性.
- 阿斯科布酸的剂量分别为50,100和200毫克/体重千克.
- 对采集的血液样本进行生物化学分析,以评估抗氧化剂状况和肝酶.
主要成果:
- 阿斯科布酸的使用恢复了肝酶的水平:血清谷氨酸氧酸酸氨酸酶,血清谷氨酸-酸氨酸酶和血清酸酸酶.
- 抗氧化酶,包括超氧化物转化酶和催化酶,显示恢复.
- 观察到促炎性标记物,如瘤亡因子-α,白内素-1β,白内素-6,甲醇和氧化的减少.
结论:
- 亚酸表现出显著的肝脏保护作用.
- 根基清除和细胞因子抑制被确定为阿斯科布酸肝脏保护的潜在机制.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...